Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bedaquiline fumarate (TMC207), a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections. It blocks the proton pump for ATP synthase of mycobacteria. It is the first member of a new class of drugs called diarylquinolines.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 72.00 | |
25 mg | In stock | $ 113.00 | |
50 mg | In stock | $ 155.00 | |
100 mg | In stock | $ 198.00 | |
200 mg | In stock | $ 297.00 | |
500 mg | In stock | $ 516.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 71.00 |
Description | Bedaquiline fumarate (TMC207), a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections. It blocks the proton pump for ATP synthase of mycobacteria. It is the first member of a new class of drugs called diarylquinolines. |
Synonyms | TMC 207, R403323, TMC-207, TMC207, R-403323, R 403323 |
Molecular Weight | 671.59 |
Formula | C36H35BrN2O6 |
CAS No. | 845533-86-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (40.95 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bedaquiline fumarate 845533-86-0 Microbiology/Virology Antibacterial Antibiotic TMC 207 R403323 Bedaquiline R-207910 inhibit Bacterial Inhibitor TMC-207 TMC207 R207910 Bedaquiline Fumarate R 207910 R-403323 R 403323 inhibitor